BioXcel Therapeutics, Inc. Shares Outstanding (Cover Page)
BioXcel Therapeutics, Inc. (BTAI) had Shares Outstanding (Cover Page) of 31.31 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 31.31M shares.
- 2026-05-14: Entity Common Stock, Shares Outstanding 30.88M shares.
- 2026-03-26: Entity Common Stock, Shares Outstanding 27.07M shares.
- 2025-11-11: Entity Common Stock, Shares Outstanding 21.87M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 31.31M shares 10-Q · filed 2026-08-13 |
| 2026-05-14 | 30.88M shares 10-Q · filed 2026-05-15 |
| 2026-03-26 | 27.07M shares 10-K · filed 2026-03-27 |
| 2025-11-11 | 21.87M shares 10-Q · filed 2025-11-12 |
| 2025-08-11 | 14.56M shares 10-Q · filed 2025-08-12 |
| 2025-05-09 | 6.06M shares 10-Q · filed 2025-05-12 |
| 2025-03-26 | 5.49M shares 10-K · filed 2025-03-28 |
| 2024-10-31 | 42.75M shares 10-Q · filed 2024-11-14 |
| 2024-07-22 | 40.74M shares 10-Q · filed 2024-08-06 |
| 2024-05-07 | 37.53M shares 10-Q · filed 2024-05-09 |
| 2024-03-18 | 30.58M shares 10-K · filed 2024-03-22 |
| 2023-11-10 | 29.27M shares 10-Q · filed 2023-11-14 |
| 2023-08-10 | 29.27M shares 10-Q · filed 2023-08-14 |
| 2023-05-03 | 29.16M shares 10-Q · filed 2023-05-09 |
| 2023-03-13 | 29.01M shares 10-K/A · filed 2023-05-01 |
| 2022-11-07 | 28.02M shares 10-Q · filed 2022-11-14 |
| 2022-08-08 | 28.02M shares 10-Q · filed 2022-08-11 |
| 2022-05-05 | 27.99M shares 10-Q · filed 2022-05-09 |
| 2022-03-01 | 27.98M shares 10-K · filed 2022-03-11 |
| 2021-11-05 | 27.98M shares 10-Q · filed 2021-11-10 |
| 2021-08-05 | 27.97M shares 10-Q · filed 2021-08-10 |
| 2021-05-05 | 24.63M shares 10-Q · filed 2021-05-10 |
| 2021-03-01 | 24.57M shares 10-K · filed 2021-03-12 |
| 2020-11-01 | 24.37M shares 10-Q · filed 2020-11-12 |
| 2020-08-11 | 22.35M shares 10-Q · filed 2020-08-14 |
| 2020-05-04 | 20.21M shares 10-Q · filed 2020-05-12 |
| 2020-03-09 | 20.18M shares 10-K · filed 2020-03-09 |
| 2019-11-08 | 18.04M shares 10-Q · filed 2019-11-14 |
| 2019-07-31 | 15.73M shares 10-Q · filed 2019-08-06 |
| 2019-05-01 | 15.67M shares 10-Q · filed 2019-05-07 |
| 2019-03-11 | 15.66M shares 10-K · filed 2019-03-12 |
| 2018-11-07 | 15.65M shares 10-Q · filed 2018-11-09 |
| 2018-08-07 | 15.65M shares 10-Q · filed 2018-08-08 |
| 2018-05-09 | 15.65M shares 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |